Infectious complications are a major cause of morbidity and mortality in patients with primary or secondary immunodeficiency. Prevention of infectious diseases by vaccines is among the most effective healthcare measures mainly for these subjects. However immunocompromised people vary in their degree of immunosuppression and susceptibility to infection and, therefore, represent a heterogeneous population with regard to immunization. To date there is no well- established evidence for use of vaccines in immunodeficient patients, and indications are not clearly defined even in high-quality reviews and in most of the guidelines prepared to provide recommendations for the active vaccination of immunocompromised hosts. The aim of this document is to issue recommendations based on published literature and the collective experience of the Italian primary immunodeficiency centers, about how and when vaccines can be used in immunocompromised patients, in order to facilitate physician decisions and to ensure the best immune protection with the lowest risk to the health of the patient.

Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET) / Martire, Baldassarre; Azzari, Chiara; Badolato, Raffaele; Canessa, Clementina; Cirillo, Emilia; Gallo, Vera; Graziani, Simona; Lorenzini, Tiziana; Milito, Cinzia; Panza, Raffaella; Moschese, Viviana. - In: VACCINE. - ISSN 0264-410X. - 36:24(2018), pp. 3541-3554. [10.1016/j.vaccine.2018.01.061]

Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET)

Milito, Cinzia;
2018

Abstract

Infectious complications are a major cause of morbidity and mortality in patients with primary or secondary immunodeficiency. Prevention of infectious diseases by vaccines is among the most effective healthcare measures mainly for these subjects. However immunocompromised people vary in their degree of immunosuppression and susceptibility to infection and, therefore, represent a heterogeneous population with regard to immunization. To date there is no well- established evidence for use of vaccines in immunodeficient patients, and indications are not clearly defined even in high-quality reviews and in most of the guidelines prepared to provide recommendations for the active vaccination of immunocompromised hosts. The aim of this document is to issue recommendations based on published literature and the collective experience of the Italian primary immunodeficiency centers, about how and when vaccines can be used in immunocompromised patients, in order to facilitate physician decisions and to ensure the best immune protection with the lowest risk to the health of the patient.
2018
Primary immunodeficiency; Secondary immunodeficiency; Syndromic immunodeficiency; Vaccination; Adult; Bacterial Infections; Bacterial Vaccines; Child; Health Policy; Humans; Immunization Schedule; Immunologic Deficiency Syndromes; Italy; Process Assessment (Health Care); Vaccination; Vaccines, Inactivated; Viral Vaccines; Virus Diseases; Immunocompromised Host; Practice Guidelines as Topic; Molecular Medicine; Immunology and Microbiology (all); Veterinary (all); Public Health, Environmental and Occupational Health; Infectious Diseases
01 Pubblicazione su rivista::01a Articolo in rivista
Vaccination in immunocompromised host: Recommendations of Italian Primary Immunodeficiency Network Centers (IPINET) / Martire, Baldassarre; Azzari, Chiara; Badolato, Raffaele; Canessa, Clementina; Cirillo, Emilia; Gallo, Vera; Graziani, Simona; Lorenzini, Tiziana; Milito, Cinzia; Panza, Raffaella; Moschese, Viviana. - In: VACCINE. - ISSN 0264-410X. - 36:24(2018), pp. 3541-3554. [10.1016/j.vaccine.2018.01.061]
File allegati a questo prodotto
File Dimensione Formato  
Martire_Vaccination-immunocompromised_2018.pdf

accesso aperto

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 545.21 kB
Formato Adobe PDF
545.21 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1183897
Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 32
  • ???jsp.display-item.citation.isi??? 28
social impact